Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines

Nicolás A. Muena, Tamara García-Salum, Catalina Pardo-Roa, Eileen F. Serrano, Jorge Levican, María José Avendaño, Leonardo I. Almonacid, Gonzalo Valenzuela, Estefany Poblete, Shirin Strohmeier, Erick Salinas, Denise Haslwanter, Maria Eugenia Dieterle, Rohit K. Jangra, Kartik Chandran, Claudia González, Arnoldo Riquelme, Florian Krammer, Nicole D. Tischler, Rafael A. Medina
doi: https://doi.org/10.1101/2021.05.17.21257197

Data Availability

The data supporting the findings of this study are available within the article and its supplementary material. The raw data that support the findings of this study are available on request from the corresponding author.

Back to top
Posted May 18, 2021.
Download PDF
Data/Code
Email
Long-lasting neutralizing antibody responses in SARS-CoV-2 seropositive individuals are robustly boosted by immunization with the CoronaVac and BNT162b2 vaccines
Nicolás A. Muena, Tamara García-Salum, Catalina Pardo-Roa, Eileen F. Serrano, Jorge Levican, María José Avendaño, Leonardo I. Almonacid, Gonzalo Valenzuela, Estefany Poblete, Shirin Strohmeier, Erick Salinas, Denise Haslwanter, Maria Eugenia Dieterle, Rohit K. Jangra, Kartik Chandran, Claudia González, Arnoldo Riquelme, Florian Krammer, Nicole D. Tischler, Rafael A. Medina
medRxiv 2021.05.17.21257197; doi: https://doi.org/10.1101/2021.05.17.21257197
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area